Quick Answer
Vivos Therapeutics, Inc. reported Long Term Debt of $423.0 thousand for the year ending 2020.
- This data is from Vivos Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2022.
- XBRL data for this metric is available from 2020 to 2020 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $105.9 thousand | Q2 2025: $7.76 million | Q3 2025: $8.38 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: